Some South African Rubiaceae Tree Leaf Extracts Have Antimycobacterial Activity Against Pathogenic and Non‐pathogenic Mycobacterium Species

Tuberculosis (TB) caused by Mycobacterium tuberculosis remains an ongoing threat to human health. Many plant species contain antimycobacterial compounds, which may serve as template molecules for new anti‐TB drugs. The Rubiaceae family is the largest family of trees in southern Africa, and preliminary evidence revealed antimycobacterial activity in several species of the genus, motivating further studies. Leaf extracts of 15 tree species from the Rubiaceae family were screened for antimycobacterial activity against pathogenic M. tuberculosis and non‐pathogenic Mycobacterium smegmatis, Mycobacterium aurum and Mycobacterium bovis BCG (Bacillus Calmette‐Guérin) using a twofold serial microdilution assay. Cytotoxicity was determined using a tetrazolium‐based colorimetric assay against C3A liver cells and Vero kidney cells. Minimum inhibitory concentration values as low as 0.04 mg/mL against M. smegmatis and M. tuberculosis were recorded. Activity against M. aurum was the best predictor of activity against pathogenic M. tuberculosis (correlation coefficient = 0.9). Bioautography indicated at least 40 different antimycobacterial compounds in the extracts. Cytotoxicity of the extracts varied, and Oxyanthus speciosus had the most promising selectivity index values. Copyright © 2015 John Wiley & Sons, Ltd.

[1]  J. Eloff,et al.  Which tree orders in southern Africa have the highest antimicrobial activity and selectivity against bacterial and fungal pathogens of animals? , 2014, BMC Complementary and Alternative Medicine.

[2]  A. Michel,et al.  Evaluation of the discriminatory power of variable number of tandem repeat typing of Mycobacterium bovis isolates from southern Africa. , 2013, Transboundary and emerging diseases.

[3]  Virgilio Bocanegra-García,et al.  Recent advances in antitubercular natural products. , 2012, European journal of medicinal chemistry.

[4]  W. Bishai,et al.  Heightened Vulnerability to MDR-TB Epidemics after Controlling Drug-Susceptible TB , 2010, PloS one.

[5]  P. Lobue,et al.  Tuberculosis in humans and animals: an overview. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  V. Kuete,et al.  Potential of Cameroonian Plants and Derived Products against Microbial Infections: A Review , 2010, Planta medica.

[7]  V. Kouznetsov,et al.  Antimycobacterial susceptibility testing methods for natural products research , 2010, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[8]  M. Shiloh,et al.  To catch a killer. What can mycobacterial models teach us about Mycobacterium tuberculosis pathogenesis? , 2010, Current opinion in microbiology.

[9]  N. Saliba,et al.  Anti-Inflammatory properties of Salograviolide A purified from Lebanese plant Centaurea ainetensis , 2009, BMC complementary and alternative medicine.

[10]  N. Brummitt,et al.  A Global Assessment of Distribution, Diversity, Endemism, and Taxonomic Effort in the Rubiaceae1 , 2009 .

[11]  A. Humpage,et al.  Cytotoxicity Screening for the Cyanobacterial Toxin Cylindrospermopsin , 2009, Journal of toxicology and environmental health. Part A.

[12]  R. L. Mancera,et al.  New anti-tuberculosis drugs in clinical trials with novel mechanisms of action. , 2008, Drug discovery today.

[13]  N. Lall,et al.  The potential of South African plants against Mycobacterium infections. , 2008, Journal of ethnopharmacology.

[14]  N. Lall,et al.  Purified compounds and extracts from Euclea species with antimycobacterial activity against Mycobacterium bovis and fast-growing mycobacteria. , 2008, Biological & pharmaceutical bulletin.

[15]  M. Bates,et al.  Comparison of pulmonary and extrapulmonary tuberculosis in Nepal- a hospital-based retrospective study , 2008, BMC infectious diseases.

[16]  Thierry Langer,et al.  Molecule-pharmacophore superpositioning and pattern matching in computational drug design. , 2008, Drug discovery today.

[17]  J. Eloff,et al.  Evaluation of Athrixia bush tea for cytotoxicity, antioxidant activity, caffeine content and presence of pyrrolizidine alkaloids. , 2007, Journal of ethnopharmacology.

[18]  D. Newman,et al.  Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.

[19]  N. H. Fischer,et al.  New perspectives on natural products in TB drug research. , 2005, Life sciences.

[20]  Linda Johnson,et al.  To Catch a killer , 2005 .

[21]  Niresh Bhagwandin,et al.  In vitro antiplasmodial activity of medicinal plants native to or naturalised in South Africa. , 2004, Journal of ethnopharmacology.

[22]  P. Houghton,et al.  Extraction of antibacterial compounds from Combretum microphyllum (Combretaceae) , 2002 .

[23]  J. Eloff On expressing the antibacterial activity of plant extracts - a small first step in applying scientific knowledge to rural primary health care. , 2000 .

[24]  J. Eloff A Sensitive and Quick Microplate Method to Determine the Minimal Inhibitory Concentration of Plant Extracts for Bacteria , 1998, Planta medica.

[25]  J. Eloff Which extractant should be used for the screening and isolation of antimicrobial components from plants? , 1998, Journal of ethnopharmacology.

[26]  Y. Amdekar,et al.  Multidrug resistant tuberculosis. , 1998, Indian pediatrics.

[27]  K. Duncan,et al.  High-throughput screen for detecting antimycobacterial agents , 1995, Antimicrobial agents and chemotherapy.

[28]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[29]  W. J. Begue,et al.  The use of tetrazolium salts in bioautographic procedures. , 1972, Journal of chromatography.